This document discusses how pharmaceutical companies can transform pharmacovigilance and adherence tools into customer experience management. It notes that the age of blockbuster drugs is over and new approaches are needed using big data, mobile apps, and a focus on preventative medicine and patient empowerment. Poor medication adherence is a major issue, compromising the real-world benefits of drugs, but new digital technologies now allow companies to better support patients and improve outcomes. Case studies show how mobile apps and remote coaching can significantly increase adherence and patient satisfaction for conditions like asthma and eczema.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
Training Program for Medical Representatives by Anup Soans Anup Soans
“Hardknocks for GreenHorn is a good book and very useful tool for any one starting his / her career in Pharma Industry..
It covers all basic concepts i.e Medical Part, Sales Tools, Innovative methods and much more. I strongly recommend this book to be the part of freshers training batch in any Pharma Company. .”
As strategists, we find inspiration everywhere.. Every month, people on our team share their muse - someone or something that is a guiding light for their work. So instead of another trend report this time of year, this is our Barkley muse report.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
Training Program for Medical Representatives by Anup Soans Anup Soans
“Hardknocks for GreenHorn is a good book and very useful tool for any one starting his / her career in Pharma Industry..
It covers all basic concepts i.e Medical Part, Sales Tools, Innovative methods and much more. I strongly recommend this book to be the part of freshers training batch in any Pharma Company. .”
As strategists, we find inspiration everywhere.. Every month, people on our team share their muse - someone or something that is a guiding light for their work. So instead of another trend report this time of year, this is our Barkley muse report.
Optimize Medical Representatives Visits using My Sales DialerAnjul Katare
Pharmaceutical Industry relies heavily on Medical Representatives (MR) for feedback, sale and constant touch with doctors and hospitals. This presentation demonstrates how My Sales Sales Dialer solution can optimize MRs work with remote management and tracking of agents.
Job of a Medical Representative is very challenging. They have to achieve their sales target by generating prescriptions in favor of their products.Here is the list of traits which are needed to become a successful Medical Representative is given below.
Role of Medical Representative | PharmaaddaAditiMehra14
Know what is the Role of Medical Sale Representative from this article. If you are looking for more information regarding the Role of Medical representative then visit http://www.pharmaadda.in/role-of-medical-representative
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
Optimize Medical Representatives Visits using My Sales DialerAnjul Katare
Pharmaceutical Industry relies heavily on Medical Representatives (MR) for feedback, sale and constant touch with doctors and hospitals. This presentation demonstrates how My Sales Sales Dialer solution can optimize MRs work with remote management and tracking of agents.
Job of a Medical Representative is very challenging. They have to achieve their sales target by generating prescriptions in favor of their products.Here is the list of traits which are needed to become a successful Medical Representative is given below.
Role of Medical Representative | PharmaaddaAditiMehra14
Know what is the Role of Medical Sale Representative from this article. If you are looking for more information regarding the Role of Medical representative then visit http://www.pharmaadda.in/role-of-medical-representative
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
Patient-centered pharmacovigilance represents a pivotal shift in the landscape of healthcare, emphasizing the active involvement of patients in the monitoring and reporting of adverse drug reactions. Unlike traditional pharmacovigilance, which primarily relies on healthcare professionals to identify and document adverse events, this approach recognizes patients as critical stakeholders in ensuring medication safety. By empowering patients to share their experiences, concerns, and observations regarding medication effects, whether positive or negative, healthcare systems can gain a comprehensive understanding of drug safety and efficacy in real-world settings. Patient-centered pharmacovigilance fosters a collaborative partnership between patients, healthcare providers, and regulatory agencies, promoting transparency, accountability, and ultimately, better patient outcomes. Through increased patient engagement and the utilization of patient-reported data, this approach enables healthcare systems to identify potential safety issues earlier, tailor treatment strategies to individual needs, and enhance overall drug safety surveillance efforts.
Patient Engagement is growing in importance as consumer expectations of healthcare providers change and as portals and other technologies improve. Early studies show affects on outcomes for patient engagement technologies
SCOPE 2015: Online Communities & Mobile Communication Impact on Recruitment ...Imperial CRS
In a joint presentation with Dennis Upah of Remedy Health Media, Melynda Geurts of DAC Patient Recruitment Services discusses the impact of online communities and mobile communication on patient recruitment and retention for clinical trials.
The explosion in the number of applications (apps) designed for the medical and wellness sectors has been noted by many. Recently we have seen increased presence of truly medical apps, in addition to consumer health and wellbeing apps, designed for clinical professionals and patients with medical conditions.
Consumer based mHealth apps typically allow people to do old things in new ways, such as recording health measures digitally rather than on paper. We see this also with medical apps, where increases in the quality and efficiency of existing health care models provide clinical staff with digital tools that replace paper based documentation. In rare and exciting cases we are also seeing mHealth applications that are doing things in entirely new ways to drive real innovation in health care delivery through mobile devices.
The aim of the tutorial is to highlight real world, high impact mobile research that is relevant to the key discipline of Mobile HCI. Thus, the tutorial will be application rather than academically focused. The tutorial will highlight the wide range of mHealth applications available that go far beyond trackers and behavior change tools and encourage researchers to look beyond consumer applications in their research. Four key areas of mHealth applications will be covered including Apps for the HealthyWell, mHealth in Hospitals, Practice and Clinical Apps and Patient Apps and will cover applications for health assessment, treatment and triage, behavior change, chronic illness, mental health, adolescent health, rehabilitation and age care with a focus on the need for rigorous evaluation and efficacy analysis.
Ομιλία – Παρουσίαση: Raymond Anderson, President Commonwealth Pharmaceutical Association and Member of the Pharmacovigilance Risk Assessment Committee (PRAC) at EMA
«Best Practices to inform citizens on Self-medication»
MicroGuide app, pop up uni, 1pm, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
1. HOW TO TRANSFORM
PHARMACOVIGILANCE
& ADHERENCE
INTO CUSTOMER
EXPERIENCE
MANAGEMENT TOOLS
2. AGE OF BLOCKBUSTERS IS OVER
New Age is about:
• Big data crunching
• MedApps
• Preventive medicine
• eHealth records
• DNA databanks
• Tissue and cell banks
• Regenerative medicine
• Nanotechnology
• Patient power
3. PROMOTION, SALES AND
ADVERTISING IS RESTRICTED
Directives:
• 2001/83/EC
• 2004/27/EC Amending
Directive 2001/83/EC
• EFPIA Code on the
Promotion to HCP
• Rx vs Non-Rx
• To Public vs to HCPs
• PATINET – central to
regulators
4. SOCIAL MEDIA IS NEW METRICS FOR
DRUG SUCCESS
• Online patient conversations and information is growing
exponentially
• Switching is a major topic of patient online discussion.
5. CROWD KNOWS WHO IS THE BEST …
Source http://treato.com/Humira/?a=s&for=RA#Effectiveness
6. PHARMACOVIGILANCE – TREAT OR
OPPORTUNITY
• Module VI of the Good
Pharmacovigilance Practice
Guidelines
• Prescription Medicines Code
of Practice Authority (PMCPA)
issued helpful guidance for
the industry on digital
communications
• Company sponsored
websites
• MedApps
• Non-company sponsored
websites
Source: http://www.pmcpa.org.uk/
7. PATIENTS CONCERNS VS. HCP
CONCERNS
Source http://treato.com/Rheumatoid+Arthritis/?a=s
Humira HCP Concerns:
• Infections
• Tuberculosis
• Hepatitis B reactivation
• Neurological events
• Immunosuppression
• Malignancies
• Hematologic reactions
• Congestive Hart Failure
• Autoimmune process
• …
Source: EMA
8. ARE WE AT THE TURNING POINT ?
“Janssen Healthcare Innovation is
developing products and services to
transform the patient experience and
promote better health outcoes .
We have identified improving medication
adherence as one of our key initiatives .”
Diego Miralles, M .D ., Head of Janssen
Healthcare Innovation
“We have a better picture of what
patients want from us and expect from
us. That allows our R&D staff to think
about the patient much earlier on in
development and ultimately will lead to a
much better solution for patients in the
long run.”
John Koconis, president and CEO,
LEO Pharma Inc.
YES
9. WHY THE FOCUS ON ADHERENCE
NOW?
• Payers, Providers,
Regulators and Pharma
have shared goal to
achieve best outcomes
from medicine use
• Real life value of
medicines to patients and
society is compromised by
poor adherence
• Increased behavioral
understanding and digital
technology has created
new opportunities
12. RESEARCH: PREVALENCE OF NON-ADHERENCE
IN ASTHMA
1/5 of adult patients never fill the script
Average adherence rate: 47.5%
Rate of clinically sufficient treatment days: 34%
Self-monitoring (daily peak-flow): 39%
Diary over 6 months: 16.5%
Correct usage of inhaler: 25-30%
Prof Stephan Mühlig, TU Chemnitz
15. CASE STUDY: ECEMA MED-APP
Baseline
Parents record
current behavior
for 2 weeks using
eczema app.
Support
programme
Patients receive
education pack
+ 30 min coaching
call with eczema
specialist nurse
Follow up
Parents record
adherence &
outcomes post
intervention for 2
weeks, and for
another week at
months 2 & 3
Source: Mrs. Marianne Gries, Regulanet Confernece
16. CASE STUDY: ECEMA MED-APP
• A UK phone coaching programme to bring
emollient adherence closer in line with
NICE guidelines
• Increase adherence & patient happiness,
reduce eczema symptoms and referrals to
the GP & Specialist
• Avg. 206% increase in adherence, 100%
reported increased happiness, 81%
reported significant reduction in eczema
symptoms.
- Average 206% increase in emollient use
- 81% of patients recorded a significant
improvement in eczema symptoms 3 months
after the support intervention
- Significant reduction in average GP visits after
intervention. 1.9 pre coaching call down to 0.13
in following months
Results independently analysed by The Robertson Centre for Biostatistics, Glasgow
University
STUDY: Improved emollient use reduces atopic eczema symptoms and is cost neutral
in infants: before-and-after evaluation of a multifaceted educational support programe
J M Mason; BMC Dermatology 2013, 13:7
18. REGULANET INTERNATIONAL
JV Partners
Germany; England,
Croatia; Portugal;
FarmavitaR+
30+ staff and associates
regulanet ®
250+ staff and
associates
FarmavitaR+ RA Community
(www.farmavitar.com)
1000+ registered users
worldwide
FarmavitaR+ - 15 countries
EU – Czech, Slovakia, Hungary,
Slovenia, Croatia, Bulgaria. Romania
Non-EU – Turkey, Ukraine, Serbia,
Bosnia&Herzegovina, Montenegro,
Macedonia, Kosovo, Albania
regulanet® - 90 countries
Rest of EMEA, USA, Japan, Brazil,
Russia, India, China, Canada, GCC
countries, Mercosur countries, Africa
Our talent pool, worldwide
NETWORK
19. CONTACT US
Zdravko Mauko, Director
Farmavita Regulanet Ltd.
Okicka desni odvojak 2,
10430 Samobor
Croatia
Phone: +385/1/3377-058
Fax: +385/1/777 6314
info@farmavitar.com
www.farmavitar.com
Editor's Notes
EU Member States must prohibit the advertising to the general public of medicinal products which:
Are available on medical prescription only;
Contain psychotropic or narcotic substances;
Are not intended for use without the intervention of a medical practitioner.
The EFPIA HCP Code covers all methods of promotion including, but not limited to, oral and written promotional activities and communications, journal and direct mail advertising, the activities of Medical Sales Representatives, the use of internet and other electronic communications, the use of audio-visual systems such as films, video recordings, data storage services and the like, and the provision of samples, gifts and hospitality.
As the industry focuses on understanding the guidelines and how to execute against them, we find that the larger point is that the regulators clearly recognizes the value of patient conversations on the Internet. The key for Pharma is how to leverage this new force in healthcare: the online empowered patient. We see the benefits that the Internet brings to patients every day. The more data we garner on patient experiences, the more informed the pharmaceutical industry becomes, in decision-making around medications and treatments.
In this context, the patient insights available through user generated content can help pharma gain the relevant information they need to become true partners with patients and caregivers.
Exceeding the Patient Demand for Responsiveness. Embracing social media will require a willingness to move beyond the tightly controlled environment to which pharma is accustomed to take their patient-focused communications to a whole new level. No doubt navigating in the realm of immediate, transparent and responsive social media communications will come with a steep learning curve.For those willing to take it on the rewards can be great because immediacy, transparency and responsiveness are precisely what patients online have come to expect. It’s apparent in the hundreds of thousands of posts we see patients generate daily across more than 3,000 social health sites to voice their concerns, needs, fears and hopes when its comes to their health.
Social media can predict the success of a new drug launch much faster than traditional methods. Many pharmaceutical companies try to measure the success of their launch based on weekly script trends. The difference between social media data and data derived from prescriptions is significant: social media data can predict the future, while script data record the past.
Company Treato distills the patient voice from billions of patient-written social media posts on over 2,000 health blogs and forums. They filter out the patient experiences from the spam and other noise and analyze them using proprietary Natural Language Processing algorithms in our Big Data processing servers. The result is unique insights into drugs, conditions, and all that’s in between.
Online patient conversations and information is growing exponentially but understanding and leveraging that data remains a challenge for most pharmaceutical companies. Smaller pharma companies have been quicker to embrace the patient voice as a valuable real-time information source as they felt it more intuitive, unbiased and cost-effective than traditional market research.
“Social Media” for healthcare information is often incorrectly used interchangeably to refer to just two key networks, Twitter and Facebook. Consumers do not want to talk about sensitive health issues on their personal profiles. They are turning to thousands of anonymous health sites where they can ask questions and discuss their first hand health experiences without fear of personal exposure or their privacy being compromised.
European pharmacovigilance legislation calls for increased participation by patients and consumers in the pharmacovigilance process and company sponsored websites can be useful tools to this end.
Companies have a high degree of control over company-sponsored websites, which are important sources of safety information and can be designed to facilitate pharmacovigilance. Web pages can provide access to adverse event reporting tools or include free text fields, to report suspected side effects. Other components like 'Terms and Conditions' or formal site registration can be used to enable companies identify and contact users to validate and follow-up on safety information. Moderation processes can also be implemented for companies to define actions to be taken in response to safety information being posted.
On company-sponsored websites, details of all adverse events or product complaints for the company's products needs to be collected and documented. The date the information was posted on the site and the date that anyone from the company or working on behalf of the company first becomes aware of the information must also be acknowleged.
Companies may release company sponsored apps for smart phones and tablet computers, where the app user can post comments on a non-company-sponsored site such as the app store through which the app is made available. Companies would not routinely be required to monitor app review comments posted on these platforms which are considered non-company sponsored digital media. However, if the company periodically reviews these comments for other purposes, any adverse event or product complaint identified should be collected and reported appropriately. Adverse event reporting is performed according to strict timelines but as there is no legal requirement to monitor non-company sponsored sites. Day zero is the day that the company first becomes aware of the adverse event or product complaint. Content generated via the app itself is to be treated as a company sponsored digital activity.
Companies may become aware of adverse events or product complaints on non-company-sponsored public portals or micro-blogging sites where content can be viewed by many site users. The company has a responsibility to follow-up these reports and should consider the most appropriate method of follow-up to protect patient confidentiality. For example, the company may direct the site user to contact the company via the company website, email or phone to provide further information.
Negative trends:
• Weaker pipelines
• More rigid reimbursement rules – comparison to gold standard
• Greater transparency / internet
• Competitive pressure – disrupting trends
• Success of innovations not just measured in clinical trials, but in real life
Disruptive trends:
Era of Blockbusters is over
Big data chanching
eHealth records
DNA databanks
Tissue and cell banks
Regenerative medicine
MedApps
Solution : Disrupt of be disrupted!